Triplicate Dynamic Cell Culture Platform for Enhanced Reproducibility in Anti-Cancer Drug Testing
ACS Biomaterials Science & Engineering · 2025
DOI: 10.1021/acsbiomaterials.4c02142 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Yu-Lun Lu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, National Tsing Hua University, Hsinchu 30013, Taiwan. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cell Culture Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Tsing Hua University, National Science and Technology Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, National Tsing Hua University, Hsinchu 30013, Taiwan.
ORCID-Profile: Jen-Huang Huang
Förderung
- National Tsing Hua University
- National Science and Technology Council
Zitieren
APA
Lu, Y. L., Lin, C. M., & Huang, J. H. (2025). Triplicate Dynamic Cell Culture Platform for Enhanced Reproducibility in Anti-Cancer Drug Testing. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.4c02142
Vancouver
Lu YL, Lin CM, Huang JH. Triplicate Dynamic Cell Culture Platform for Enhanced Reproducibility in Anti-Cancer Drug Testing. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.4c02142
BibTeX
@article{Lu2025,
author = {Lu, Yu-Lun and Lin, Chiao-Min and Huang, Jen-Huang},
title = {Triplicate Dynamic Cell Culture Platform for Enhanced Reproducibility in Anti-Cancer Drug Testing},
journal = {ACS Biomaterials Science & Engineering},
year = {2025},
doi = {10.1021/acsbiomaterials.4c02142}
}
EUVIMED